Volume : 11, Issue : 09, September – 2024
Title:
MULTIDISCIPLINARY APPROACH TO CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) MANAGEMENT
Authors :
Omar Baker Banamah, Batool Abbas Almishkab, Nada Faiez Alshanbari, Shimaa Fahad Alradadi, Usama Ibrahem Ibrahem Badr, Salwa Ahmed Osman, Hamed Saeed Alghamdi, Ibrahim Ali Alhussain, Fatimah Hassan Muhanna, Afraa Abdulrahman Aljahdali, Abdullah Saeed Alzaki, Sultan Saeed Alharbi, Sarah Mohammed Alnassar, Marwah Thani Hawsawi, Mayssan Hussein Ali Almalki
Abstract :
Background: A multidisciplinary approach to Chronic Obstructive Pulmonary Disease (COPD) management is essential for optimizing patient outcomes, as it integrates various therapeutic strategies tailored to individual needs. This approach combines pharmacological treatments with non-pharmacological interventions, addressing the disease’s respiratory and systemic aspects. Integrating different healthcare professionals and personalized care plans has been shown to improve lung function, reduce exacerbations, and enhance the quality of life for COPD patients.
Objective: an overview of COPD etiology, pathophysiology, and management.
Methods: The PUBMED And Google Scholar Search Engines Were the Main Databases Used for The Search Process, With Articles Collected From 1970 To 2024.
Conclusion: COPD is a common and severe respiratory disorder with far-reaching health, economic, and social effects, particularly growing in developing areas. Its main cause is cigarette smoking, alongside environmental and genetic factors, emphasizing the importance of awareness and early intervention for better patient care. The condition leads to chronic inflammation and airflow limitations, resulting in symptoms like breathlessness and cough, which require thorough diagnosis and tailored treatment. A holistic management strategy, including pharmacological and non-pharmacological approaches, is vital for improving patients’ overall quality of life.
Keywords: etiology, risk factor, pathophysiology, manifestation, diagnosis, management, copd.
Cite This Article:
Please cite this article in press Omar Baker Banamah et al., Multidisciplinary Approach To Chronic Obstructive Pulmonary Disease (COPD) Management., Indo Am. J. P. Sci, 2024; 11 (09).
Number of Downloads : 10
References:
1. Lahousse L. Epidemiology of Comorbidities in Chronic Obstructive Pulmonary Disease. 2014.
2. Wier LM, Elixhauser A, Pfuntner A, Au DH. Overview of hospitalizations among patients with COPD, 2008. 2011.
3. Umoh VA. An overview of chronic obstructive pulmonary disease (COPD): epidemiology and pathogenesis. The Nigerian Health Journal. 2012;12(3):55-64.
4. Rodrigues SO, Cunha C, Soares GMV, Silva PL, Silva AR, Gonçalves-de-Albuquerque CF. Mechanisms, Pathophysiology and Currently Proposed Treatments of Chronic Obstructive Pulmonary Disease. Pharmaceuticals (Basel). 2021;14(10).
5. Paré P, Sandford A. Genetic risk factors of chronic obstructive pulmonary disease. Swiss medical weekly. 2002;132(0304):27-37.
6. Muro S. Cigarette smoking is the most important causal factor for developing chronic obstructive pulmonary disease (COPD). Nihon rinsho Japanese Journal of Clinical Medicine. 2011;69(10):1735-40.
7. Ullmer, Solèr, Perruchoud. Etiology, diagnosis and therapy of COPD. Therapeutische Umschau. 1999;56(3):125-30.
8. Chiba H, Abe S. The environmental risk factors for COPD–tobacco smoke, air pollution, chemicals. Nihon rinsho Japanese Journal of Clinical Medicine. 2003;61(12):2101-6.
9. Russell R, Ford P, Barnes P, Russell R, Ford P, Barnes P. Epidemiology, risk factors and pathophysiology. Managing COPD. 2011:7-28.
10. Maestrelli P. [Pathophysiology of chronic obstructive pulmonary disease]. Ann Ist Super Sanita. 2003;39(4):495-506.
11. MacNee W. Pathology, pathogenesis, and pathophysiology. Bmj. 2006;332(7551):1202-4.
12. Chhabra SK, Dash DJ. Acute exacerbations of chronic obstructive pulmonary disease: causes and impacts. Indian J Chest Dis Allied Sci. 2014;56(2):93-104.
13. Urbano F, Mohsenin V. Chronic obstructive pulmonary disease and sleep: the interaction. Panminerva medica. 2006;48(4):223-30.
14. Stephens MB, Yew KS. Diagnosis of chronic obstructive pulmonary disease. American family physician. 2008;78(1):87-92.
15. Currie GP, Legge JS. ABC of chronic obstructive pulmonary disease. Diagnosis. Bmj. 2006;332(7552):1261-3.
16. Sanders C. The radiographic diagnosis of emphysema. Radiologic Clinics of North America. 1991;29(5):1019-30.
17. Kon SS, Canavan JL, Nolan CM, Jones SE, Clark AL, Polkey MI, et al. The clinical chronic obstructive pulmonary disease questionnaire: cut point for GOLD 2013 classification. American Journal of Respiratory and Critical Care Medicine. 2014;189(2):227-8.
18. Mullerova H, Locantore N, Jones P. GOLD assessment of COPD patients: Impact of symptoms assessment choice. Eur Respiratory Soc; 2012.
19. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3):648-54.
20. JA BM, Martinez TY, FP LG, de Castro Pereira CA. Dyspnea scales as a measure of health-related quality of life in patients with idiopathic pulmonary fibrosis. Medical science monitor: international medical journal of experimental and clinical research. 2002;8(6):CR405-10.
21. Kew KM, Dahri K. Long‐acting muscarinic antagonists (LAMA) added to combination long‐acting beta2‐agonists and inhaled corticosteroids (LABA/ICS) versus LABA/ICS for adults with asthma. Cochrane Database of Systematic Reviews. 2016(1).
22. Anderson DE, Kew KM, Boyter AC. Long‐acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS alone for adults with asthma. Cochrane Database of Systematic Reviews. 2015(8).
23. Dong Y-H, Hsu C-L, Li Y-Y, Chang C-H, Lai M-S. Bronchodilators use in patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease. 2015:1769-79.
24. Gillissen A. Medikamentöse Therapie der COPD. In: Lingner H, Schwartz F-W, Schultz K, editors. Volkskrankheit Asthma/COPD: Bestandsaufnahme und Perspektiven. Berlin, Heidelberg: Springer Berlin Heidelberg; 2007. p. 249-55.
25. Yang IA, Clarke MS, Sim EHA, Fong KM. Inhaled corticosteroids for stable chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews. 2012(7).
26. Simeone JC, Luthra R, Kaila S, Pan X, Bhagnani TD, Liu J, et al. Initiation of triple therapy maintenance treatment among patients with COPD in the US. International journal of chronic obstructive pulmonary disease. 2016:73-83.
27. Bhoomadevi M, Ganesh M, Panchanatham N. Designing a conceptual model for patient-centered care–a patient perspective. Res J Sci IT Manag. 2014;3(5):20-4.
28. Vogelmeier C, Hederer B, Glaab T, Schmidt H, Rutten-van Mölken MP, Beeh KM, et al. Tiotropium versus salmeterol for the prevention of exacerbations of COPD. New England Journal of Medicine. 2011;364(12):1093-103.
29. Decramer ML, Chapman KR, Dahl R, Frith P, Devouassoux G, Fritscher C, et al. Once-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group study. The lancet Respiratory medicine. 2013;1(7):524-33.
30. Currie GP, Douglas JG. Non-pharmacological management. BMJ. 2006;332(7554):1379-81.
31. Heslop K. Non-pharmacological treatment of anxiety and depression in COPD. Nurse Prescribing. 2014;12(1):43-7.
32. Clini E, Costi S, Lodi S, Rossi G. Non-pharmacological treatment for chronic obstructive pulmonary disease. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research. 2003;9(12):RA300-5.
33. Golish JA, Ahmad M. Management of COPD. Postgraduate Medicine. 1977;62(1):131-6.
Volume : 11, Issue : 09, September – 2024
Title:
THE EFFECT OF EQUIPPING AMBULANCES WITH RAPID COMMUNICATION MECHANISMS IN RESPONDING QUICKLY TO THE INJURED IN EMERGENCY SITUATIONS
Authors :
Zaher Ali Awadh Alshehri., MADINE MNAJI MOHAMMED ALSHAREIF . Yasser Yahya Amer Alhabis ., Mohammed Abdullah Awwadh Al-Harthi., Mohammed Mnaji Mohammed Alshareif., Othman Mabruk Faraj Alotaibi., Marzouq Masad Bin Hamdan Alhathla.
Abstract :
The current study aimed to identify the impact of equipping ambulances with rapid communication mechanisms on the response time for injured individuals in emergency situations. This was achieved by employing a descriptive analytical approach through the distribution of a questionnaire consisting of 500 emergency medical technicians to assess their opinions regarding the equipping of ambulances and rapid communication mechanisms. The study’s results indicated that there was no statistical significance attributed to professional and occupational experiences or the number of years of service concerning the responses of the sample on the questionnaire. The study presented several findings, including that technological advancements have facilitated the provision of higher quality communication means in ambulances, ensuring various solutions for rapid access to victims in emergencies. Furthermore, the implementation of precise location identification technology has enhanced response speed and helped avoid traffic congestion. The study’s results also indicated that the quicker the access to the accident scene, the greater the chances of survival for the injured, and that there is an effect of delayed response on rescue opportunities.
Key words: Technique, technology, response speed, communication methods, rapid access methods.
Cite This Article:
Please cite this article in press Zaher Ali Awadh Alshehri et al., The Effect Of Equipping Ambulances With Rapid Communication Mechanisms In Responding Quickly To The Injured In Emergency Situations, Indo Am. J. P. Sci, 2024; 11 (09).
Number of Downloads : 10
References:
1- Gulsen, M. F., Kurt, M., Kaleli, I., & Ulasti, A. (2020). Personal protective equipment (ppe) using in antalya 112 emergency ambulance services during outbreak. medRxiv, 2020-06.
2- Lyng, J., Adelgais, K., Alter, R., Beal, J., Chung, B., Gross, T., … & Yee, A. (2021). Recommended essential equipment for basic life support and advanced life support ground ambulances 2020: a joint position statement. Pediatrics, 147(6).
3- Rosiello, F., Zelinotti, L., Monti, M., Cosmi, P., Procacciante, M., Petrelli, G., … & Serale, M. (2020). Decontamination of ambulance and equipment, a problem for worker safety and national security. In 2nd Scientific International Conference on CBRNe SICC Series| 2020 Epidemics, biological threats, and radiological events. The importance of a multidisciplinary approach for International Research Cooperation Book of Abstract (pp. 69-69). tab editore.
4- Tiwary, B., Nilima, N., Majumdar, P., Singh, M., & Khan, M. A. (2020). Quality of services provided by public funded ambulance program: experience from a northern state in India. Clinical epidemiology and global health, 8(3), 962-966.
5- Chen, L., Tang, T. Q., Song, Z., Guo, R. Y., & Huang, H. J. (2022). Empirical investigation of child evacuation under non-emergency and emergency situations. Journal of Transportation Safety & Security, 14(4), 585-606.
6- Xakimovich, A. S., & Qaxramonjon o’g’li, Z. H. (2022). Prediction of Situations That May Occur in Emergency Situations of Bridges by Means of Optical Sensors. Texas Journal of Engineering and Technology, 13, 55-59.
7- Kyrkou, C., Kolios, P., Theocharides, T., & Polycarpou, M. (2022). Machine learning for emergency management: A survey and future outlook. Proceedings of the IEEE, 111(1), 19-41.
8- Idland, S., Iversen, E., Brattebø, G., Kramer-Johansen, J., & Hjortdahl, M. (2022). From hearing to seeing: medical dispatchers’ experience with use of video streaming in medical emergency calls− a qualitative study. BMJ open, 12(12), e063395.
9- Alarilla, A., Stafford, M., Coughlan, E., Keith, J., & Tallack, C. (2022). Why have ambulance waiting times been getting worse?. Health Found.
10- Olani, A., Beza Demisse, L., Alemayehu, M., & Sultan, M. (2022). Factors Associated with Willingness to Call Emergency Medical Services for Worsening Symptoms of COVID-19 in Addis Ababa, Ethiopia. Open Access Emergency Medicine, 563-572.
11- Rabeea’h, W. A., Snooks, H., Porter, A., Khanom, A., Cole, R., Edwards, A., … & Watkins, A. (2022). STRategies to manage Emergency ambulance Telephone Callers with sustained High needs: an Evaluation using linked Data (STRETCHED)–a study protocol. BMJ open, 12(3), e053123.
12- Marincowitz, C., Stone, T., Hasan, M., Campbell, R., Bath, P. A., Turner, J., … & Goodacre, S. (2022). Accuracy of emergency medical service telephone triage of need for an ambulance response in suspected COVID-19: an observational cohort study. BMJ open, 12(5), e058628.
13- Brady, L., Gilson, L., George, A., Vries, S. D., & Hartley, S. (2024). A community-based ambulance model: lessons for emergency medical services and everyday health systems resilience from South Africa. Health policy and planning, czae070.
14- Wennlund, K. T., Kurland, L., Olanders, K., Khoshegir, A., Al Kamil, H., Castrén, M., & Bohm, K. (2022). Emergency medical dispatchers’ experiences of managing emergency calls: a qualitative interview study. BMJ open, 12(4), e059803.
15- GÖKÇEDAĞ, Ş. Y. (2023). AMBULANCE ACCIDENTS BETWEEN 2016-2021 AND THEIR INVESTIGATION IN TERMS OF OCCUPATIONAL HEALTH AND SAFETY1. Current Research in Health Sciences.
16- Mulyono, N. B., Pambudi, N. F., Ahmad, L. B., & Adhiutama, A. (2022). Determining response time factors of emergency medical services during the COVID-19 pandemic. International Journal of Emergency Services, 11(1), 154-167.